ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

バルサラジド

5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid

HCID 54585
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
80573-04-2
標準SMILES
O=C(O)CCNC(=O)c1ccc(N=Nc2ccc(O)c(C(=O)O)c2)cc1
InChIKey
IPOKCKJONYRRHP-UHFFFAOYSA-N
分子式
C17H15N3O6
平均分子量
357.32 g/mol
単同位体質量
357.0960852

概要

Balsalazide is a monohydroxybenzoic acid consisting of 5-aminosalicylic acid (mesalazine) linked to 4-aminobenzoyl-beta-alanine via an azo bond. It has a role as a non-steroidal anti-inflammatory drug, an anti-ulcer drug, a prodrug and a gastrointestinal drug. It is a conjugate acid of a balsalazide(2-).

名称と識別子

優先名称
5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acid
IUPAC
5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid
現地名
バルサラジド
英語名
Balsalazide
分子式
C17H15N3O6
分子量
357.32

名称と別名

5-((4-((2-carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acidDTXSID508610275-({4-[(2-Carboxyethyl)carbamoyl]phenyl}diazenyl)-2-hydroxybenzoic acidRefChem:1072307DTXCID10810339BALSALAZIDE80573-04-2BalsalazidoBalsalazidaBalsalazidumBalsalazidum [Latin]Balsalazida [Spanish]
名称をさらに表示
バルサラジドCS-1360BalsalazineBalsalazide D4Balsalazide 98%BALSALAZIDE SODIUM
Balsalazido [Spanish](E)-5-((4-((2-Carboxyethyl)carbamoyl)phenyl)diazenyl)-2-hydroxybenzoic acidColazalGiazo(E)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acidColazideBalsalazide (INN)DTXSID7040653

データベース識別子

CAS
80573-04-2
PubChem CID
54585
DTXSID
DTXSID50861027
ChEMBL
CHEMBL1208641

物性

構造計算による物性補完中

XLogP
2.2
極性表面積
149 Ų
水素結合供与体数
4
水素結合受容体数
8
回転可能結合数
7
重原子数
26
形式電荷
0
複雑度
545

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
SolubilityFreely soluble as disodium salt

物理化学的性質

融点
254 · 254-255C
沸点
729.6 · 729.6±60.0 °C(Predicted)
比重(密度)
1.44 · 1.44±0.1 g/cm3(Predicted)
蒸気圧
0 Pa · 0Pa at 20℃
貯蔵温度
-20 °C · -20°C Freezer
溶解性
DMSO(微量)、メタノール(微量)
外見
個体
酸解離定数(Pka)
2.97 · 2.97±0.10(Predicted)
色
黄色からベージュ
InChI
InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+
InChIKey
IPOKCKJONYRRHP-FMQUCBEESA-N
SMILES
C(O)(=O)C1=CC(/N=N/C2=CC=C(C(NCCC(O)=O)=O)C=C2)=CC=C1O
LogP
1 at · 1 at 25℃ and pH7.5

化学と産業

薬理情報

Protein Binding≥99%
Pharmacodynamics · 1 件

Balsalazide is a prodrug that has little or no pharmacologic activity until it is enzymatically cleaved in the colon to produce mesalamine (5-aminosalicylic acid), an anti inflammatory drug indicated for the treatment of mildly to moderately active ulcerative colitis. Balsalazide disodium is delivered intact to the colon where it is cleaved by bacterial azoreduction to release equimolar quantities of mesalamine, which is the therapeutically active portion of the molecule, and the intert 4-aminobenzoyl-(beta)-alanine. As a result, the spectrum of pharmacologic activity of balsalazide is similar to that of mesalamine.

Mechanism of Action · 1 件

The mechanism of action of 5-aminosalicylic acid is unknown, but appears to exert its anti-inflammatory effects locally (in the GI tract) rather than systemically. Mucosal production of arachidonic acid metabolites, both through the cyclooxygenase pathways (catalyzes the formation of prostaglandin precursors from arachidonic acid), and through the lipoxygenase pathways (catalyzes the formation of leukotrienes and hydroxyeicosatetraenoic acids from arachidonic acid and its metabolites), is increased in patients with chronic inflammatory bowel disease. Therefore, it is possible that 5-aminosalicylic acid diminishes inflammation by blocking production of arachidonic acid metabolites in the colon through both the inhibition of cyclooxygenase and lipoxygenase.

Biological Half-LifeHalf-life could not be determined.
Metabolism/MetabolitesCleaved in the colon via bacterial azoreduction to 5–aminosalicylic acid (5–ASA) and 4–aminobenzoyl-beta-alanine, the inactive carrier moiety.
Absorption, Distribution and Excretion · 2 件

Low and variable, intact balsalazide is poorly absorbed systemically.

The products of the azoreduction of this compound, 5-ASA and 4-aminobenzoyl-ß-alanine, and their N-acetylated metabolites have been identified in plasma, urine and feces. Following single-dose administration of 2.25 g COLAZAL (three 750 mg capsules) under fasting conditions in healthy subjects, mean urinary recovery of balsalazide, 5-ASA, and N-Ac-5-ASA was 0.20%, 0.22% and 10.2%, respectively.

関連反応

5 件
反応記録を作成
HRID 916723 の反応式
HRID 916723生成物として
HRID 1750338 の反応式
HRID 1750338反応物として
HRID 2202207 の反応式
HRID 2202207反応物として
HRID 2205960 の反応式
HRID 2205960反応物として
HRID 2272552 の反応式
HRID 2272552反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性化学と産業関連反応化合物ノート
ChEBI
CHEBI:267413
UNII
P80AL8J7ZP
EPAの化学物質情報
5 · Benzoic acid, 5-[(1E)-2-[4-[[(2-carboxyethyl)amino]carbonyl]phenyl]diazenyl]-2-hydroxy- (80573-04-2)

化学的性質

化学的特性Yellow Solid

応用分野 · 2 件

説明Balsalazide is a prodrug form of 5-aminosalicylic acid (5-ASA; ). It is cleaved by bacterial azoreductases in the intestinal lumen to release 5-ASA. Balsalazide (600 mg/kg per day) decreases IL-2 levels and increases IL-6 levels in the serum and colonic mucosa membrane, as well as decreases micro- and macroscopic colonic damage, in a rat model of colitis induced by 2,4-dinitrochlorobenzene (DNCB). Formulations containing balsalazide have been used in the treatment of ulcerative colitis.

使用An analogue of Sulfasalazine, A prodrug of 5-Aminosalicylic Acid

上流・下流製品情報

上流原料

亜硝酸ナトリウムL-アラニン4-ニトロベンゾイル クロリド2-ヒドロキシ安息香酸

補足説明

定義ChEBI: A monohydroxybenzoic acid consisting of 5-aminosalicylic acid (mesalazine) linked to 4-aminobenzoyl-beta-alanine via an azo bond.